trending Market Intelligence /marketintelligence/en/news-insights/trending/wY3P8fEuL-qlu-sy4ahdaQ2 content esgSubNav
In This List

Natera prices $200M common stock offering

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Natera prices $200M common stock offering

Natera Inc. priced its public offering of 5,714,286 common shares at $35 apiece.

The San Carlos, Calif.-based company also granted underwriters a 30-day option to buy up to an additional 857,142 common shares at the same price.

Gross proceeds from the offering, based on the offering size and per-share price, are expected to reach about $200 million.

The offering is expected to close on Oct. 21.

J.P. Morgan, Morgan Stanley, Cowen and Piper Jaffray are acting as joint book-running managers for the offering, while Baird and Craig-Hallum Capital Group are co-managers.

Natera offers preconception and prenatal genetic testing services. In May, its custom test to detect tumor DNA received breakthrough device designation from the U.S. Food and Drug Administration.